Posted on 2/3/20
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Bristol-Myers Squibb (NYSE:BMY) announced on Friday afternoon that it has withdrawn its European application for the company's Opdivo/Yervoy lung cancer drug combo. The company had hoped . . .
Posted on 2/3/20
5 Reasons Pfizer Is Big Pharma's Top Dividend Stock to Buy Right Now
Pfizer (NYSE:PFE) recently reported fourth-quarter earnings that missed expectations on the top and bottom line. As a result, a jumpy stock market knocked a few percentage . . .
Posted on 2/3/20
In a Mixed Quarter, Johnson & Johnson Shows Off Its Greatest Strength
Johnson & Johnson (NYSE:JNJ) is the largest healthcare company in the world, but that hasn't stopped the pharma giant from encountering headwinds. It is currently involved . . .
Posted on 2/3/20
Pfizer's Biosimilar Ruxience Gets EU Regulatory Backing
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on Friday recommended that the European Commission approve Pfizer's (NYSE:PFE) drug Ruxience, a biosimilar . . .
Posted on 2/3/20
Johnson & Johnson Keeps Growing Despite Ongoing Legal Woes
Johnson & Johnson (NYSE:JNJ) released its fourth-quarter earnings on Jan. 22. The results were mixed, with earnings per share of $1.88, which came in above analyst . . .
Posted on 2/3/20
Johnson & Johnson Ordered to Pay $344 Million for Deceptively Marketing Pelvic Mesh Product
Johnson & Johnson (NYSE:JNJ) was hit with a $344 million fine by a California state court for deceptively marketing regarding its pelvic mesh products. This ruling . . .
Posted on 2/3/20
Phreesia Named 2020 Best in KLAS For Patient Intake Management
NEW YORK--(BUSINESS WIRE)--Phreesia today announced it has been named 2020 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its . . .
Posted on 2/2/20
Ambra Health Named Top Medical Image Exchange Vendor by KLAS For the Sixth Year in a Row
Ambra Health, makers of the leading cloud-based, medical image management suite, today announced its recognition as the 2020 KLAS Category Leader for Image Exchange. This is . . .
Posted on 1/31/20
Infectious Disease Expert at Northern Westchester Hospital Available to Discuss What We Know About Coronavirus
New information continues to emerge about coronavirus, a respiratory illness that was identified in Wuhan City, China, and is now being closely monitored by the Centers . . .
Posted on 1/31/20
Ben Kallos Joins ProHEALTH Care at Ribbon Cutting to Open the First Pediatric Urgent Care in Manhattan
ProHEALTH Care, the largest independent, physician-run health system in the nation, hosted a ribbon-cutting ceremony to open the first pediatric-only urgent care in Manhattan. Council Member . . .
Posted on 1/31/20
Is Pfizer Stock a Buy?
Last Tuesday, pharmaceutical titan Pfizer (NYSE:PFE) reported its 2019 fourth-quarter earnings. This underwhelming Q4 report -- in conjunction with the downturn in the broader markets due . . .
Posted on 1/31/20
Vertex Pharmaceuticals Reports Q4 Financial Earnings, Beats Estimates
Vertex Pharmaceuticals (NASDAQ:VRTX) announced its fourth-quarter financial results on Thursday afternoon, which were above analyst expectations. For the three months ending on Dec. 31, Vertex reported . . .
Posted on 1/31/20
Stemline Therapeutics: Down, But Not Out
SummaryToday we revisit Stemline Therapeutics, whose stock has fallen some 35% this month on disappointing preliminary Q4 revenue guidance.However, the company's ELZONRIS franchise and the stock . . .
Posted on 1/31/20
Tonix Pharmaceuticals Moves Ahead, And Other News: The Good, Bad, And Ugly Of Biopharma
SummaryTonix Pharmaceuticals moves ahead with TNX 102 SL.TrovaGene jumps on data.Principia gets bearish coverage.Looking for more stock ideas like this one? Get them exclusively at The . . .
Posted on 1/30/20
Novartis Reports Q4 2019 Financial Results, Zolgensma Sales Fall Short
Swiss pharmaceutical giant Novartis (NYSE:NVS) announced its fourth-quarter 2019 financial results this morning. The company reported net sales of $12.4 billion, which was up 8% in . . .
Posted on 1/30/20
Is Merck Still a Strong Buy?
Merck (NYSE:MRK) has long been the apple of investors' eyes, both for its excellent financials and solid dividend payouts. The company enjoyed monumental sales growth in . . .
Posted on 1/30/20
Johnson & Johnson Joins the Hunt for a Coronavirus Vaccine
Biopharmaceutical giant Johnson & Johnson (NYSE:JNJ) is mobilizing dozens of scientists to research the genetic code of the Wuhan coronavirus in hopes of developing a vaccine . . .
Posted on 1/30/20
Black Diamond Therapeutics Prices IPO
CAMBRIDGE, Mass. and NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ: BDTX), a precision oncology medicine company pioneering the discovery and . . .
Posted on 1/29/20
Gracie Square Hospital Psychiatrist Offers Tips on Overcoming Addiction
Many people who are trying to overcome substance-use disorders face powerful cravings that can be triggered by anything from emotions to the environment. In fact, the . . .
Posted on 1/29/20
Biohaven Announces Pricing Of $250 Million Public Offering Of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical?stage biopharmaceutical company with a portfolio of innovative, late?stage product candidates targeting neurological diseases, including rare disorders, today . . .
Posted on 1/29/20
Current Health Collaborates with Mass General Hospital
NEW YORK--(BUSINESS WIRE)--Current Health, which offers the leading FDA-cleared, artificial intelligence (AI)-powered patient management platform, today announced that it will collaborate with Massachusetts General Hospital (MGH) . . .
Posted on 1/29/20
Pfizer's Q4 Results, 2020 Guidance Leave Investors Cold
Pharmaceutical giant Pfizer (NYSE:PFE) reported fourth-quarter results Tuesday that beat expectations for revenue, but missed on the bottom line. That miss, combined with weak profit guidance, . . .
Posted on 1/29/20
Johnson & Johnson's Nasal Spray Rejected in England Over Cost-Effectiveness
One of Britain's top healthcare agencies, the National Institute for Health and Care Excellence (NICE), announced on Tuesday that the group had decided to reject Johnson . . .
Posted on 1/29/20
Biohaven Announces Proposed Public Offering Of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical?stage biopharmaceutical company with a portfolio of innovative, late?stage product candidates targeting neurological diseases, including rare disorders, today . . .
Posted on 1/29/20
Applied Therapeutics Closes Public Offering of Common Stock
NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
New York
